Atlas Trials

Extension Study of BIIB092 in Participants With Progressive Supranuclear Palsy (PSP) Who Participated in CN002003

Clinical trial NCT02658916 · TERMINATED

Trial details

NCT number
NCT02658916
Sponsor
Biogen
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Supranuclear Palsy, Progressive
Start date
2016-02-22
Primary completion
2020-03-31
Enrollment
47

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.